Previous 10 | Next 10 |
home / stock / hbp:cc / hbp:cc news
(TheNewswire) Toronto, O N - TheNewswire - March 15, 2023 - Helix BioPharma Corp. (TSX:HBP) , (“ Helix ” or the “ Company ”), a clinical-stage biopharmaceutical company developing unique therapies in the field of im...
(TheNewswire) Toronto, Ontario – TheNewswire – January 24, 2023 - Helix BioPharma Corp. (TSX:HBP) (“Helix” or the “Company”), a clinical-stage biopharmaceutical company developing unique therapies in the field of immuno-oncology, based on it...
(TheNewswire) Toronto, O N - TheNewswire - January 9, 2023 - Helix BioPharma Corp. (TSX:HBP) (“Helix” or the “Company”), a clinical-stage biopharmaceutical company developing unique therapies in the field of immuno-oncology, based ...
(TheNewswire) Toronto, Ontario – Thenewswire – December 14, 2022 – Helix BioPharma Corp. (TSX:HBP), (“ Helix ” or the “ Company ”), a clinical-stage biopharmaceutical company developing unique therapies in ...
(TheNewswire) Toronto, O N – TheNewswire - December 8, 2022 - Helix BioPharma Corp. (TSX:HBP) (“Helix” or the “Company”), a clinical-stage biopharmaceutical company developing unique therapies in the field of immuno-oncology, based on its pro...
(TheNewswire) NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Toronto, Ontario – TheNewswire – November 3, 2022 - Helix BioPharma Corp. (TSX:HBP) (“Helix” or the “...
(TheNewswire) Toronto, Ontario – TheNewswire – November 1, 2022 - Helix BioPharma Corp. (TSX:HBP), (“ Helix ” or the “ Company ”), a clinical-stage biopharmaceutical company developing unique therapies in the fi...
(TheNewswire) October 3, 2022 – TheNewswire - Toronto, Ontario – Helix BioPharma Corp . (TSX:HBP) (OTC:HBPCF) (“Helix” or the “Company”), a clinical-stage biopharmaceutical company that is developing unique therapie...
(TheNewswire) Toronto, Ontario – TheNewswire – September 1, 2022 – Helix BioPharma Corp . (TSX:HBP) (“Helix” or the “Company”), a clinical-stage biopharmaceutical company that is developing unique therapies in the fi...
(TheNewswire) Toronto, Ontario – TheNewswire – August 30, 2022 – Helix BioPharma Corp. (TSX:HBP) (“Helix” or the “Company”), a clinical-stage biopharmaceutical company that is developing unique therapies in the field of ...
News, Short Squeeze, Breakout and More Instantly...
Helix BioPharma Corp. Company Name:
HBP:CC Stock Symbol:
TSXC Market:
Helix BioPharma Corp. Website:
Crown Capital Partners Inc. (CRWN:CA) is expected to report for Q1 2024 Aberdeen International Inc. (AAB:CA) is expected to report for Q1 2025 Haivision Systems Inc. (HAI:CA) is expected to report for Q2 2024 Peyto Exploration & Development Corp. (PEY:CA) is expected to report $0....
Batero Gold Corp. (BAT:CA) is expected to report for Q2 2024 Barrick Gold Corporation (ABX:CA) is expected to report $0.22 for Q1 2024 Exco Technologies Limited (XTC:CA) is expected to report $0.17 for Q2 2024 Amerigo Resources Ltd. (ARG:CA) is expected to report for Q1 2024 Parkl...
Wall Financial Corporation (WFC:CA) is expected to report for quarter end 2024-01-31 Helix BioPharma Corp. (HBP:CA) is expected to report for Q2 2024 Choice Properties Real Estate Investment Trust (CHP.UN:CA) is expected to report $0.26 for Q1 2024 Celestica Inc. Subordinate Voting Sh...